Akademik Veri Yönetim Sistemi
CA21125 INE-CSC COST Action Conference The Next Chapter: Impowering Individiuals, Families, And Society for Cancer Survivorship & Supportive Care, Coimbra, Portekiz, 25 - 26 Mayıs 2026, (Yayınlanmadı)
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a
common and dose-limiting adverse effect of neurotoxic chemotherapy agents.
Clinical monitoring remains limited due to time constraints, lack of resources,
underreporting, and the subjective nature of assessments. Emerging digital
health solutions—including mobile health applications, wearable sensors, and
electronic patient-reported outcome systems—offer new opportunities for
continuous, objective, and patient-centered symptom monitoring. In oncology nursing,
implementing these systems plays a critical role in interpreting CIPN-related
data and improving symptom management.
Aim: This scoping review aimed to identify digital
technologies developed between 2019 and 2025 for the monitoring and assessment
of CIPN and to examine their applicability in nursing practice.
Methods: A systematic search was conducted in the Web of
Science, PubMed, and Scopus databases for studies published between 2019 and
2025. Inclusion criteria comprised studies utilizing digital methods for
measuring or monitoring CIPN symptoms with relevance to nursing practice. Data
were categorized according to study design, sample characteristics, technology
type, and the role of nurses.
Key Messages / Findings: Literature
highlights that mobile health applications (e.g., NeuroDetect, Neuropathy
Tracker), wearable sensors (accelerometer-based systems measuring parameters
such as balance, gait, and manual dexterity), and ePRO systems have emerged as
key tools for the early detection and management of CIPN. Most studies reported
that nurse-led use of these technologies facilitated objective and real-time
symptom tracking, leading to reductions in symptom severity and duration, and
improvements in self-care competence. However, some decision-support systems
demonstrated limited effectiveness due to low user engagement and insufficient
integration into clinical workflows.
Conclusion: Integrating digital tools into oncology nursing
practice is essential for the comprehensive and data-driven management of CIPN.
Future priorities include conducting broader studies across all neurotoxic
agents, developing theory-based and user-centered digital systems, enhancing
nurses’ digital literacy, and establishing international guidelines for digital
monitoring.